Article
Factors affecting the loss of MED12-mutated leiomyoma cells during in vitro growth.
Oncotarget - 23 May 2017
Bloch Jeannine, Holzmann Carsten, Koczan Dirk, Helmke Burkhard Maria, Bullerdiek Jörn
Abstract excerpt
Uterine leiomyomas (UL) are the most prevalent symptomatic human tumors at all and somatic mutations of the gene encoding mediator subcomplex 12 (MED12) constitute the most frequent driver mutations in UL. Recently, a rapid loss of mutated cells during in vitro growth of UL-derived cell cultures was reported, resulting in doubts about the benefits of UL-derived cell cultures. To evaluate if the rapid loss of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
